Inventor · disambiguated record
Kamel Khalili
Also filed as: KHALILI KAMEL
17 granted patents·59 pending applications·53 citations·filing 2001–2024
92Inventor score
Files withUNIV TEMPLE57EXCISION BIOTHERAPEUTICS INC7TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION5CAN FITE BIOPHARMA LTD1KHALILI KAMEL1
Top patents by PatentIndex Score
76 records- 0196US9925248B2Methods and compositions for RNA-guided treatment of HIV infectionUNIV TEMPLE·Filed 2014·Granted Mar 27, 2018·16 cites·13 claims
- 0295US11273209B2Methods and compositions for RNA-guided treatment of HIV infectionTemple University—Of the Commonwealth System of Higher Education·Filed 2020·Granted Mar 15, 2022·3 cites·6 claims
- 0393US11542555B2BAG3 as a target for therapy of heart failureUNIV TEMPLE·Filed 2020·Granted Jan 3, 2023·4 cites·17 claims
- 0491US11291710B2Methods and compositions for RNA-guided treatment of HIV infectionUNIV TEMPLE·Filed 2020·Granted Apr 5, 2022·2 cites·15 claims
- 0590US11491207B2Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapyEXCISION BIOTHERAPEUTICS INC·Filed 2019·Granted Nov 8, 2022·7 cites·10 claims
- 0690US9981020B2Methods and compositions for RNA-guided treatment of HIV infectionUNIV TEMPLE·Filed 2016·Granted May 29, 2018·2 cites·4 claims
- 0788US2024139294A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2023·Application pending·0 cites
- 0887US11298411B2Methods and compositions for RNA-guided treatment of HIV infectionUNIV TEMPLE·Filed 2018·Granted Apr 12, 2022·1 cites·8 claims
- 0987US11285193B2Methods and compositions for RNA-guided treatment of HIV infectionUNIV TEMPLE·Filed 2018·Granted Mar 29, 2022·1 cites·8 claims
- 1084US2025250562A1Tat-induced crispr/endonuclease-based gene editingUNIV TEMPLE·Filed 2024·Application pending·0 cites
- 1184US2025082778A1Rna guided eradication of human jc virus and other polyomavirusesUNIV TEMPLE·Filed 2024·Application pending·0 cites
- 1284US2023181698A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2022·Application pending·0 cites
- 1382US7589075B2Use of an adenosine A3 receptor agonist for inhibition of viral replicationCAN FITE BIOPHARMA LTD·Filed 2002·Granted Sep 15, 2009·12 cites·16 claims
- 1481US11236389B2BAG3 as a target for therapy of heart failureUNIV TEMPLE·Filed 2015·Granted Feb 1, 2022·4 cites·23 claims
- 1579US2022313795A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2021·Application pending·0 cites
- 1677US2021252114A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2020·Application pending·0 cites
- 1775US2018236045A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2018·Application pending·0 cites
- 1875US2018303915A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2018·Application pending·0 cites
- 1975US2018221458A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2018·Application pending·0 cites
- 2075US2023193257A1Tat-induced crispr/endonuclease-based gene editingUNIV TEMPLE·Filed 2022·Application pending·0 cites
- 2175US2018207243A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2018·Application pending·0 cites
- 2274US2018228875A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2018·Application pending·0 cites
- 2374US2023001016A1Rna guided eradication of human jc virus and other polyomavirusesUNIV TEMPLE·Filed 2022·Application pending·0 cites
- 2474US2018228876A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2018·Application pending·0 cites
- 2574US2018236046A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2018·Application pending·0 cites
- 2674US2018228874A1Methods and compositions for rnra-guided treatment of hiv infectionUNIV TEMPLE·Filed 2018·Application pending·0 cites
- 2774US2018236044A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2018·Application pending·0 cites
- 2874US2018169193A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2018·Application pending·0 cites
- 2974US2018200343A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2018·Application pending·0 cites
- 3072US2023233654A1Gene editing methods and compositions for eliminating risk of jc virus activation and pml (progressive multifocal leukoencephalopathy) during immunosuppressive therapyEXCISION BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3171US12251429B2Methods and compositions for RNA-guided treatment of HIV infectionTemple University—Of the Commonwealth System of Higher Education·Filed 2020·Granted Mar 18, 2025·0 cites·1 claims
- 3271US2018214521A1Methods and compositions for rna-guided treatment of hiv infectionUNIV TEMPLE·Filed 2018·Application pending·0 cites
- 3371US2023287401A1Rna guided compositions for preventing and treating hepatitis b virus infectionsUNIV TEMPLE·Filed 2022·Application pending·0 cites
- 3470US2023167425A1Rna guided eradication of varicella zoster virusUNIV TEMPLE·Filed 2022·Application pending·0 cites
- 3570US2023073246A1Bag3 as a target for therapy of heart failureUNIV TEMPLE·Filed 2022·Application pending·0 cites
- 3666US2023390357A1Ischemia/reperfusion injuryUNIV TEMPLE·Filed 2022·Application pending·0 cites
- 3764US2023279398A1Treating human t-cell leukemia virus by gene editingTEMPLE UNIV OF THE COMMONWEALTH SYSTEM OF HIGHTER EDUCATION·Filed 2022·Application pending·0 cites
- 3863US2025135032A1Crispr methods for correcting bag3 gene mutations in vivoUNIV TEMPLE·Filed 2023·Application pending·0 cites
- 3962US11298410B2Methods and compositions for RNA-guided treatment of HIV infectionTemple University—Of the Commonwealth System of Higher Education·Filed 2016·Granted Apr 12, 2022·0 cites·16 claims
- 4062US10279014B2Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapyEXCISION BIOTHERAPEUTICS INC·Filed 2018·Granted May 7, 2019·0 cites·11 claims
- 4160US2024336939A1Crispr induced disruption of mogs geneUNIV TEMPLE·Filed 2022·Application pending·0 cites
- 4260US2024261436A1Gene editing therapy for hiv infection via dual targeting of hiv genome and ccr5UNIV TEMPLE·Filed 2022·Application pending·0 cites
- 4360US2020392487A1Excision of retroviral nucleic acid sequencesUNIV TEMPLE·Filed 2020·Application pending·0 cites
- 4457US12122997B2Excision of retroviral nucleic acid sequencesTemple University—Of the Commonwealth System of Higher Education·Filed 2017·Granted Oct 22, 2024·0 cites·11 claims
- 4557US7612039B2Method of cell growth inhibition with agnoproteinUNIV TEMPLE·Filed 2003·Granted Nov 3, 2009·1 cites·20 claims
- 4657US2024271128A1Rna guided eradication of herpes simplex type i and other related human herpesvirusesUNIV TEMPLE·Filed 2020·Application pending·0 cites
- 4757US2017333572A1Rna guided eradication of human jc virus and other polyomavirusesTEMPLE UNIV OF COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2015·Application pending·0 cites
- 4854US2019183971A1Ischemia/reperfusion injuryUNIV TEMPLE·Filed 2017·Application pending·0 cites
- 4953US2019256844A1Rna guided compositions for preventing and treating hepatitis b virus infectionsUNIV TEMPLE·Filed 2017·Application pending·0 cites
- 5052US2019093092A1Rna guided eradication of varicella zoster virusUNIV TEMPLE·Filed 2016·Application pending·0 cites
Showing the top 50 of 76 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kamel Khalili files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →